Two different questions: what happened before versus what is needed now
When you send an enquiry about an implantable cardioverter defibrillator (ICD) or cardiac resynchronisation therapy (CRT) device, the first useful distinction is between historical records and a forward-looking assessment. These are not competing documents. They answer separate questions, and a clinician needs both to give you a meaningful opinion.
Old records answer: what was implanted, when, and why. They show the original indication, the device model and manufacturer, the lead types, the settings that were programmed, and any therapies the device has delivered since. They also show how the heart's rhythm and pumping function have changed over time. Without this, a new team is looking at a patient with a device but no reliable picture of the device's history.
A new assessment answers: is the current system still appropriate, and what should happen next. That includes whether the device type still matches your clinical need, whether the leads are functioning, whether programming should change, and how follow-up checks would be arranged. It is a clinical decision, not an administrative one, and it belongs to the treating hospital.
The two questions are linked but not interchangeable. A complete old record does not automatically answer the new question, and a new assessment cannot be reliable without the old record. If you are considering care in China, the practical task is to make both available in a form the receiving team can use.
Why the device label matters: ICD, CRT-P and CRT-D are not the same
An ICD treats dangerous heart rhythms. A CRT device supports coordinated pumping when the heart's chambers do not contract in step. A CRT-D combines both functions: it provides cardiac resynchronisation and defibrillation. These labels are not interchangeable, and the distinction changes what a new assessment must cover.
If your records say only 'pacemaker' or 'CRT', the receiving team cannot tell whether a defibrillator function is present, whether resynchronisation is part of the system, or how many leads are implanted. That gap matters because the questions for the clinical team differ. For an ICD, the focus includes therapy history and programming. For a CRT device, the focus includes whether resynchronisation is still achieving its intended effect. For a CRT-D, both lines of enquiry apply.
This is also why a generic enquiry is less useful than a specific one. Instead of asking whether a device can be checked in China, ask which device and leads are proposed for review, and how programming, remote monitoring and later device checks would be coordinated. That wording gives the hospital something concrete to answer.
If you do not know your exact device type, say so. The device identification card, implant record or a recent device interrogation report can usually clarify it. The treating team should confirm the label rather than assume it from a summary.
What old records can and cannot answer
Old records are strongest on facts: the implant date, the device and lead models, the original reason for implantation, and the therapies or changes recorded since. A recent interrogation report is particularly useful because it shows current programming, battery status, lead measurements and any stored events. These are the details a new team needs before it can comment on whether the system is still appropriate.
Old records are weaker on the present question. They may not show whether your symptoms have changed, whether your heart function has changed, or whether the original programming still fits your current needs. They also may not show whether remote monitoring is active, whether the device is compatible with a particular monitoring system, or whether you have any restrictions that affect future checks.
A records-based opinion can therefore clarify the device history and identify what is missing. It cannot by itself establish final eligibility, confirm that a procedure is needed, or guarantee that a particular hospital will accept the case. Those decisions follow a clinical assessment, and the hospital makes them.
The practical step is to ask what the receiving team needs, rather than sending everything at once. A short summary first, followed by specific documents on request, is usually easier for both sides.
The new assessment: what it should clarify before any decision
A new assessment should answer several questions that old records alone cannot settle. Is the current device type still appropriate for your rhythm and pumping needs? Are the leads functioning as expected? Should programming change? Is there any sign that the system needs revision, replacement or additional evaluation? These are clinical judgements, and they depend on current information, not only historical documents.
The assessment should also clarify how follow-up would work. Device checks are not a single event. They involve scheduled interrogations, possible remote monitoring, and a plan for what happens if the device delivers therapy or if a lead problem is detected. If you are considering care in China, ask how programming, remote monitoring and later device checks would be coordinated, and who would be responsible for each part.
It is reasonable to ask the clinical team about evidence-based risk estimates and uncertainty. A responsible clinician can discuss what is known about benefits and limitations without guaranteeing an individual result. What no assessment can promise is a specific outcome, a fixed recovery course, or that a particular device or lead will be available.
If your symptoms are worsening or you have received repeated device therapies, local urgent care takes priority over an overseas enquiry. Do not delay necessary assessment while exploring options abroad.
Questions to put to the hospital before you commit
The most useful preparation is a short list of questions that the hospital can answer in writing. These are not administrative formalities; they determine whether the assessment is worth arranging and what it would involve.
Ask which device and leads are proposed for review, and whether the team needs the implant record, the device identification card, recent interrogation reports, or all three. Ask how programming, remote monitoring and later device checks would be coordinated, including who would review remote data and how often in-person checks would be expected. Ask what the written assessment would include, what it would not cover, and what further tests or consultations the treating team would decide on.
Ask how the hospital's written estimate is structured: what is included, what is excluded, and what remains undecided until after clinical review. Ask whether the review would be records-based or would require an in-person visit, and what would change that. Ask how communication would work if you do not speak Chinese, and whether an interpreter would be involved in clinical discussions.
These questions are not a substitute for the clinical assessment. They are how you decide whether to proceed with one.
- Which device and leads are proposed for review, and which records are needed?
- How would programming, remote monitoring and later device checks be coordinated?
- What would the written assessment include, and what would it not cover?
- How is the hospital's written estimate structured, and what remains undecided?
- Would the review be records-based or require an in-person visit?
- How would language and interpretation be handled during clinical discussions?
Practical preparation and a clear next step
Start with a brief summary: your main question, the device type if known, the implant date, and any recent symptoms or device therapies. Do not send a complete medical archive in the first message. After initial contact, the team can explain how to share specific records securely.
For the clinical side, the most useful documents are usually the implant record, the device identification card, and the most recent interrogation report. If you do not have them, say so; the receiving team can advise what to request from your current clinic. Do not stop or change any prescribed medication or device settings on your own.
ChinaSpecialistCare provides information and non-clinical coordination. Diagnosis, prescriptions, suitability, hospital acceptance and treatment decisions belong to the treating hospital and licensed clinicians. An initial enquiry is free and does not require buying a proxy consultation. The hospital decides whether the case is suitable for assessment.
A practical next step is to send a short summary through the enquiry form, email or WhatsApp, stating that you are asking about an ICD or CRT device and what you want the assessment to clarify. The team can then suggest the relevant next step and explain what records would be useful.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.